Chorionic gonadotropin oral

Drug Profile

Chorionic gonadotropin oral

Alternative Names: BTL-cg; HP 4; LDI-100; ML-04; ML-04A

Latest Information Update: 22 Jan 2007

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Milkhaus Laboratory
  • Class Infertility therapies; Peptide hormones; Pituitary gonadotropins; Placental hormones
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Benign prostatic hyperplasia; Myelodysplastic syndromes; Prostatitis

Most Recent Events

  • 12 Nov 2003 A study has been added to the adverse events and Mens Health therapeutic trials sections
  • 30 Jul 2003 Milkhaus has completed enrolment in a phase IIb trial for Benign prostatic hyperplasia in the US
  • 02 Apr 2003 Data from a media release have been added to the adverse events and Mens Health therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top